Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 06, 2023, titled "Sun Pharma Announces US FDA Filing Acceptance of New Drug Application (NDA) For Deuruxolitinib".
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 06, 2023, titled "Sun Pharma Announces US FDA Filing Acceptance of New Drug Application (NDA) For Deuruxolitinib".